Switching From PlushCare to PlexusDx: Cost Model, Timing, and Continui

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Switching from PlushCare to PlexusDx involves a change in service model rather than a simple prescription transfer. PlushCare operates as a telehealth visit platform that sends prescriptions for branded GLP-1 medications (Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda) to external pharmacies; your final medication cost depends on pharmacy pricing and insurance coverage. PlexusDx dispenses compounded semaglutide or tirzepatide directly at a single published monthly rate that includes the medication. To maintain continuity, coordinate timing so you have medication on hand from your current provider while your PlexusDx intake is processed, and confirm with both clinical teams how your current dose maps to a compounded protocol. The two programs cannot run concurrently under most clinical guidelines, so overlap planning centers on supply timing rather than dual prescriptions.

Service model comparison at a glance

Sources: PlushCare pricing and service model captured September 4, 2026; PlexusDx pricing captured July 17–23, 2026; PlexusDx review record captured September 4, 2026.

Cost structure: service fees versus all-in pricing

The financial case for switching hinges on your current out-of-pocket medication cost through PlushCare's external pharmacy channel. PlushCare's membership and visit fees are transparent, but the final cost depends on pharmacy pricing, insurance coverage, and manufacturer discount programs—variables not included in PlushCare's published rates. PlexusDx publishes a single monthly figure that includes medication, clinical review, and shipping.

PlushCare 12-month service cost (medication separate)

PlushCare membership operates on a subscription model with an introductory free period. Over 12 months, the service costs break down as follows (our calculation):

Monthly membership path:

• Month 1: $0 (first 30 days free introductory period)
• Months 2–12: $19.99/month × 11 = $219.89
• Initial visit: $129 (one-time)
• Total service cost over 12 months: $348.89
• Average monthly service cost: $29.07

Annual membership path (prepaid):

• Year 1 membership: $149 (prepaid)
• Initial visit: $129 (one-time)
• Total service cost over 12 months: $278
• Average monthly service cost: $23.17 (prepaid)

Medication cost: Not included in the above figures. Your out-of-pocket cost for Wegovy, Ozempic, Mounjaro, or Zepbound depends on your pharmacy, insurance plan, copay structure, and whether you qualify for manufacturer savings programs. Without insurance, branded GLP-1 list prices typically range from $900 to over $1,300 per month; with insurance and discount programs, costs vary widely.

PlexusDx 12-month all-in cost

PlexusDx includes compounded medication, clinical review, labs where indicated, and shipping in a single monthly rate with no separate membership or visit fees.

Compounded semaglutide injection (month-to-month):

• $189/month × 12 = $2,268 over 12 months
• Same price at every dose

Compounded tirzepatide injection (month-to-month):

• $289/month × 12 = $3,468 over 12 months
• Same price at every dose

Lower per-month rates are available on 3-month and 6-month commitment plans; see the weight management protocols collection for current multi-month pricing.

Like-for-like comparison

A direct cost comparison requires knowing your actual PlushCare medication expense. If your monthly out-of-pocket cost for branded medication through PlushCare's pharmacy channel—after insurance and any discount programs—exceeds approximately $160 for semaglutide or $260 for tirzepatide, PlexusDx's all-in model may reduce total spending. If your insurance covers most of your branded medication cost and your copay is lower than those thresholds, PlushCare's service-only model may remain more economical. Confirm your current medication cost at checkout with your pharmacy before finalizing a switch.

Regulatory and medication distinctions

PlushCare prescribes FDA-approved branded GLP-1 medications manufactured by Novo Nordisk (Wegovy, Ozempic, Saxenda) and Eli Lilly (Mounjaro, Zepbound). These drugs have completed the FDA's full approval process for safety, effectiveness, and manufacturing quality.

PlexusDx dispenses compounded semaglutide and tirzepatide prepared by licensed 503A compounding pharmacies. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Compounded formulations are distinct from branded medications and are not interchangeable without clinical oversight.

Because these are different medication categories, switching is not a simple prescription transfer. Your new provider will evaluate your current dose, response, and health profile to determine an appropriate starting protocol on the compounded side.

Continuity and timing: maintaining your regimen during the switch

The central continuity risk when switching GLP-1 providers is a gap between your last dose from the old program and your first dose from the new program. Here's how to coordinate timing:

Before starting your PlexusDx intake

1. Check your current supply. Note how many doses remain from your PlushCare prescription and when your next refill is due. If you're within two weeks of running out, request a refill through PlushCare before starting the PlexusDx intake to ensure overlap.

2. Gather your current regimen details. Document your current medication (Wegovy, Ozempic, Mounjaro, or Zepbound), current dose, injection frequency, and how long you've been at that dose. The PlexusDx intake will ask for this information, and a licensed provider will use it to determine your starting compounded protocol.

3. Understand that dose equivalency is a clinical decision. Branded and compounded formulations use different concentration standards and delivery mechanisms. A provider will assess your current dose and response to recommend a starting compounded dose; this is not a one-to-one conversion. Do not assume your dose will remain numerically identical.

During intake and approval

4. Complete the PlexusDx intake. The online intake collects medical history, current medications, and weight management goals. Processing time from intake submission to provider review and approval varies; plan for at least several business days.

5. Coordinate timing with your current refill cycle. If approved, your first PlexusDx shipment typically arrives within days of approval. Maintain your PlushCare prescription active until you have your first PlexusDx dose in hand. Most patients benefit from a brief supply overlap rather than cutting off the old program before the new medication arrives.

6. Do not run both programs simultaneously long-term. Using two GLP-1 prescriptions from two providers concurrently creates clinical and safety risks. The overlap is logistical—keeping supply available during the handoff—not therapeutic. Once your PlexusDx medication is in hand and you've confirmed the protocol with your new provider, discontinue your PlushCare prescription.

After receiving your first PlexusDx shipment

7. Cancel your PlushCare membership. PlushCare allows cancellation anytime with no minimum commitment. Cancel after confirming your PlexusDx supply and protocol to avoid paying for services you're no longer using.

8. Follow your new provider's dosing guidance. Your PlexusDx provider may start you at a different dose than your last branded dose, particularly if you're transitioning to a compounded formulation for the first time. Adherence to the prescribed titration schedule supports tolerance and effectiveness.

9. Report any issues promptly. If you experience supply delays, unexpected side effects during the transition, or questions about dose conversion, contact your PlexusDx clinical team immediately. Do not adjust doses independently or restart your old medication without provider input.

When switching makes sense

Choose PlushCare if…

• Your insurance covers most of your branded medication cost and your monthly copay is low. If you're paying $50 or $100 per month out-of-pocket for Wegovy or Mounjaro after insurance, PlushCare's membership and visit fees add relatively little to an already-affordable regimen.
• You prefer FDA-approved branded medications and value the regulatory distinction. Branded drugs have completed the full FDA approval process; compounded medications have not.
• Your current dose and response are stable and you see no reason to change formulations. Continuity on the same branded product avoids the transition complexity of switching to a compounded preparation.
• You benefit from PlushCare's prior-authorization support. If your insurance requires prior authorization and PlushCare's team has successfully navigated that process for you, the administrative support may justify the membership cost.

Choose PlexusDx if…

• Your out-of-pocket medication cost through PlushCare's pharmacy is high or unpredictable. If you're paying several hundred dollars per month for branded medication—or if your insurance coverage is unstable—PlexusDx's fixed monthly rate offers cost certainty.
• You're paying full list price for branded GLP-1 medication because you lack insurance or your plan doesn't cover weight management drugs. PlexusDx's compounded semaglutide at $189/month or tirzepatide at $289/month is substantially lower than uninsured branded pricing.
• You want one transparent monthly bill with medication, visits, labs, and shipping included. PlushCare's model separates service fees from medication costs; PlexusDx consolidates everything.
• You're comfortable with compounded medication and understand the regulatory distinction. Compounded drugs are not FDA-approved, and a licensed clinician evaluates whether compounded GLP-1 therapy is appropriate for your situation.

What you cannot assume about switching

Several common switching assumptions are not supported by the available evidence and should be confirmed with both clinical teams:

You cannot assume dose equivalency. A 1.0 mg weekly Wegovy dose is not automatically the same as a 1.0 mg weekly compounded semaglutide dose. Compounded formulations, concentration standards, and delivery mechanisms differ. Your new provider determines your starting compounded dose based on your history and response, not a formulaic conversion.

You cannot assume instant prescription transfer. PlushCare's prescription is written for a branded medication dispensed by an external pharmacy. PlexusDx dispenses compounded medication under a new prescription from a new provider. This is not a prescription transfer; it's a new prescription based on a new clinical evaluation.

You cannot assume automatic approval. PlexusDx providers evaluate whether compounded GLP-1 therapy is appropriate for each individual. A history of branded GLP-1 use does not guarantee approval for compounded therapy. Clinical criteria, contraindications, and appropriateness are assessed independently.

You cannot assume uninterrupted refills across the switch. Gaps can occur if you do not coordinate timing. Maintain active supply from your current provider until your new provider's medication is in hand.

Methodology and freshness

This comparison uses PlushCare pricing and service details captured September 4, 2026, from the PlushCare website, including membership rates, visit fees, and service model descriptions. PlexusDx pricing reflects rates captured July 17–23, 2026, for compounded semaglutide and tirzepatide injection programs. Review ratings for PlexusDx were captured from Trustpilot on September 4, 2026. The 12-month cost calculations are our calculations based on published rates and stated terms; they assume continuous enrollment and do not account for pauses, dosage changes, or individual insurance variables.

PlushCare's medication cost through external pharmacies was not captured and is described as variable based on insurance, pharmacy pricing, and discount programs. Readers should confirm current out-of-pocket medication costs with their pharmacy and current service pricing with both providers at the time of decision.

No verified step-by-step prescription-transfer protocols or dose-conversion tables were available in the evidence. The continuity guidance in this article reflects general best practices for medication switches and should be confirmed with the clinical teams at both PlushCare and PlexusDx.

Frequently Asked Questions

Can I transfer my PlushCare prescription directly to PlexusDx?

No. PlushCare prescribes branded FDA-approved medications; PlexusDx dispenses compounded medications under a new prescription. Switching requires a new clinical intake and provider evaluation at PlexusDx, not a prescription transfer. Your new provider will determine an appropriate compounded starting dose based on your current regimen and response.

How long does the PlexusDx intake and approval process take?

Processing time from intake submission to provider review and approval varies by individual clinical complexity and current demand. Plan for at least several business days. To avoid a gap, maintain your PlushCare supply active until your first PlexusDx shipment arrives and you've confirmed your new protocol with your provider.

Will my dose stay the same when I switch from branded to compounded medication?

Not necessarily. Branded and compounded GLP-1 formulations differ in concentration, delivery mechanism, and preparation. Your PlexusDx provider evaluates your current dose and clinical response to recommend a starting compounded dose; this is a clinical decision, not a one-to-one numerical conversion. Follow your new provider's titration guidance.

Is PlexusDx less expensive than PlushCare for everyone?

It depends on your current out-of-pocket medication cost. If your insurance covers most of your branded medication cost through PlushCare's pharmacy and your copay is low, PlushCare's service fees may keep total cost below PlexusDx's all-in rate. If you're paying several hundred dollars per month for medication or lack insurance coverage, PlexusDx's fixed monthly rate typically reduces total spending. Confirm your actual medication cost before deciding.

Can I run both programs at the same time during the transition?

No. Using two GLP-1 prescriptions from two providers concurrently creates clinical and safety risks. The goal is logistical overlap—keeping supply available during the handoff—not running dual therapy. Once your PlexusDx medication is in hand and you've confirmed your protocol, discontinue your PlushCare prescription and cancel the membership to avoid paying for unused services.

Sources

• PlexusDx product pricing and service model, plexusdx.com, accessed July 17–23, 2026
• PlushCare service overview and product offerings, plushcare.com, accessed September 4, 2026
• PlushCare membership and visit pricing, plushcare.com, accessed September 4, 2026
• Trustpilot reviews: PlushCare profile (plushcare.com) and PlexusDx rating (4.3 stars, 79% five-star, 83% four stars or higher), trustpilot.com, accessed September 4, 2026
• PlushCare labs and contract terms, plushcare.com, accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.